SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-025088
Filing Date
2023-05-16
Accepted
2023-05-16 17:30:05
Documents
6
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20009150x1_pre14a.htm PRE 14A 572138
2 logo_neurobo.jpg GRAPHIC 50705
3 ny20009150x1_barchart01.jpg GRAPHIC 152665
4 ny20009150x1_barchart02.jpg GRAPHIC 87321
5 ny20009150x1_pc1.jpg GRAPHIC 521595
6 ny20009150x1_pc2.jpg GRAPHIC 452335
  Complete submission text file 0001140361-23-025088.txt   2313733
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37809 | Film No.: 23928862
SIC: 2834 Pharmaceutical Preparations